New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
06:55 EDTTPI, TPI, TPI, ANX, ANX, ANX, AGEN, AGEN, AGEN, CTSO, CTSO, CTSO, ATOS, ATOS, ATOS, SYN, SYN, SYN, OXBT, OXBT, OXBT, CLRX, CLRX, CLRX, BONE, BONE, BONEOneMedPlace to host a forum
6th Annual OneMedForum 2013 is being held in San Francisco on January 7-9.
News For TPI;ANX;AGEN;CTSO;ATOS;SYN;OXBT;CLRX;BONE From The Last 14 Days
Check below for free stories on TPI;ANX;AGEN;CTSO;ATOS;SYN;OXBT;CLRX;BONE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
13:30 EDTSYNSynthetic Biologics confirms receipt of orphan drug designation for SYN-005
Subscribe for More Information
10:03 EDTSYNSynthetic Biologics treatment of Bordetella pertussis granted orphan status
Reference Link
09:14 EDTOXBTOn The Fly: Pre-market Movers
Subscribe for More Information
07:00 EDTSYNSynthetic Biologics to host investor day
Investor Day to be held on September 16 at 9 am. Webcast Link
September 11, 2014
17:32 EDTOXBTOxygen Biotherapeutics announces halt of Oxycyte Phase IIb trial
Subscribe for More Information
17:25 EDTOXBTOxygen Biotherapeutics trading halted, pending news
Subscribe for More Information
07:49 EDTSYNSynthetic Biologics to host conference call
Subscribe for More Information
September 10, 2014
07:09 EDTSYNAmericas Committee for Treatment & Research in MS to hold a meeting
Subscribe for More Information
September 9, 2014
09:03 EDTTPITianyin Pharmaceutical applies for Azithromycin import certificates in India
Subscribe for More Information
September 8, 2014
07:18 EDTAGENRodman & Renshaw to hold a conference
Subscribe for More Information
September 7, 2014
17:11 EDTSYNSynthetic Biologics highlights new data from C. difficile program
Synthetic Biologics announced preclinical data that further validate the company's novel approach to preventing Clostridium difficile,C. difficile. The U.S. Centers for Disease Control has identified C. difficile as an "urgent public health threat," and it has surpassed MRSA as the number one hospital-acquired infection in the United States. The data were highlighted on September 6 at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC, in Washington, D.C.
September 2, 2014
07:36 EDTSYNSynthetic Biologics announces positive results from study of SYN-004
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use